Pore-forming toxins (PFT) form the largest family of secreted toxins from pathogenic bacteria. 1, 2 Staphylococcus aureus produces different hemolysins, and α-hemolysin is one of the well-studied PFTs for which the X-ray structure of the pore is available. 1 These toxins form heptameric pores of 1-2 nm in size in cell membranes, leading to various outcomes, including apoptotic cell death, in the host cells. 2 As epithelial cells and keratinocytes are the major sites of pathogen entry, we have set out to investigate the molecular machinery driving cell death mediated by α-hemolysin in these cell types. To our surprise, we have detected an initiator caspase role for caspase-2 during PFT-mediated apoptosis, and further investigations revealed that caspase-2 is activated in a PIDDosome-independent manner under these conditions. 3 Caspases are effector proteases of the apoptotic cascade and broadly divided into two major classes depending on the structure and chronology of their activation as initiator and effector caspases. 4 Despite being the first mammalian caspases to be cloned and highly conserved, the physiological role of this caspase remains unclear. 5, 6 Caspase-2-deficient mice develop normally, with mild defects, and emerging evidence suggests a role for this caspase in regulating DNA damage response, cell cycle regulation and tumor suppression. 6 Like other initiator caspases, caspase-2 is activated by dimerization mediated through the CARD domains, and initial studies revealed that caspase-2 is recruited to a high molecular weight complex distinct from the apoptosome in cell lysates upon transfer from 4°C to 37°C. 7 During genotoxic stress, caspase-2 has been shown to be recruited to a Role for caspase-2 during pore-forming toxin-mediated apoptosis 8 However, recent studies reveal that caspase-2 can be activated in the absence of PIDDosome, which warrants for the presence of additional caspase-2 activation platforms. 9 However, whether such caspase-2 complexes are formed in apoptotic cells and the unique apoptotic stimuli where caspase-2 is activated as an initiator caspase remain unclear.
By exploiting an "in situ caspase trapping" approach employing biotin-VAD, we identified that caspase-2, but not caspase-8 or caspase-9, is precipitated as a proximal caspase during PFT-mediated apoptosis in HeLa cells. 3 Consistently, loss of caspase-2 prevented PFT-mediated apoptosis in HeLa cells and mouse embryonic fibroblasts. Interestingly, loss of either PIDD or RAIDD has failed to render protection to PFT-mediated apoptosis, and caspase-2 is activated in RAIDD-deficient cells. Caspase-2 is activated in caspase-3/7 DKO MEFs, suggesting that the activation and processing of caspase-2 under these settings is independent of effector caspases.
Intriguingly, PFT-mediated cell death is partially inhibited by loss of Bax and Bak, the major regulators of the mitochondrial outer membrane permeabilization or by the loss of effector caspases 3 and 7 (Fig. 1) . It is currently unclear how caspase-2 accomplishes Bax/Bak activation, and further, it is tempting to propose that caspase-2 might forgo the loss of these two effector caspases and cleave the relevant substrates directly to accomplish cell death (Fig. 1) . Recent studies employing N-terminal COFRADIC (combined fractional diagonal chromatography) to study the degradome of caspases revealed that the protease specificities of caspase-2 largely overlap with the effector caspases. 3, 11 The BiFc signals for caspase-2-CARD domain exhibited a punctuate staining under these settings. 3 By employing high-resolution gel filtration chromatography, we detected that caspase-2 is consistently detected in a high molecular weight fraction larger than a single ribosome (approx. 3 MDa) in the toxin-treated cells. This complex is devoid of RAIDD or PIDD, and we detect either the full-length or the processed fragments of caspase-2 in this high molecular weight complex in the apoptotic cells. Detection of full-length caspase-2 to this HMW complex suggests that caspase-2 is possibly recruited to this complex for its activation during PFT-mediated apoptosis in these cell types.
Previous studies revealed that PFTs induce K + efflux in the cells, leading to various outcomes ranging from inflammasome activation to pyroptosis to autophagy depending on the cell type and the extent of the toxin insult (Fig. 1) . As expected, inhibition of PFT-mediated K + efflux prevented the recruitment and activation of caspase-2 to the HMW complex, thus preventing cell death. Further, physiological the activation of caspases-2 upon PFT treatment. 5 In conclusion, our studies reveal unique apoptotic stimuli where caspase-2 is activated as an initiator caspase to mediate apoptotic cell death in non-lymphoid cells. These observations possibly open up new avenues to decipher potential PIDDosome-independent caspase-2 activation platforms.
concentrations of K + and Na + ions have been shown to prevent the assemblage of apoptosome as well as the activation of caspase-2 in cell-free systems. 7, 12 Whether reduction in the physiological concentrations of K + ions upon toxin treatment spontaneously led to the direct dimerization of caspase-2 needs further studies. Further, it is currently unclear if there is a concurrent increase in the intracellular calcium ion concentrations upon toxin treatment, and if there is any role for Ca 2+ influx in mediating caspase-2 activation in these cell types.
Interestingly, caspase-2 is regulated by phosphorylation under various settings, and it would be interesting to test if phosphorylation/dephosphorylation events regulate Figure 1 . Pore-forming toxins induce various forms of cell death depending on the cell type and the extent of toxin insult. in epithelial cells, caspase-2 is activated as an initiator caspase in a Piddosome-independent manner to regulate PFt-mediated cell death. the PFt-mediated cell death is partially dependent on Bax and Bak as well as on effector caspases, revealing that caspase-2 might also exhibit features of effector caspases. activation of caspase-2 has been shown to be regulated by PP1, 14-3-3 zeta and PKCK2 under various settings, and it would be interesting to characterize if caspases-2 phosphorylation regulates its activation in response to PFts.
